• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Hemorheol Microcirc . Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - a prospective observational p

tetano

Editor, Senior Moderator
Clin Hemorheol Microcirc


. 2022 Mar 21.
doi: 10.3233/CH-221401. Online ahead of print.
Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - a prospective observational pilot study


David Astapenko[SUP] 1 2 3 [/SUP], Adela Tomasova[SUP] 2 4 [/SUP], Alena Ticha[SUP] 4 [/SUP], Radomir Hyspler[SUP] 2 4 [/SUP], Huey Shin Chua[SUP] 2 [/SUP], Mubashar Manzoor[SUP] 2 [/SUP], Roman Skulec[SUP] 2 5 [/SUP], Christian Lehmann[SUP] 6 7 8 9 [/SUP], Robert Hahn[SUP] 10 11 [/SUP], Manu Lng Malbrain[SUP] 12 13 14 [/SUP], Vladimir Cerny[SUP] 1 2 3 5 6 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease (COVID-19) associated endotheliopathy and microvascular dysfunction are of concern.
Objective: The objective of the present single-center observational pilot study was to compare endothelial glycocalyx (EG) damage and endotheliopathy in patients with severe COVID-19 (COVID-19 group) with patients with bacterial pneumonia with septic shock (non-COVID group).
Methods: Biomarkers of EG damage (syndecan-1), endothelial cells (EC) damage (thrombomodulin), and activation (P-selectin) were measured in blood on three consecutive days from admission to the intensive care unit (ICU). The sublingual microcirculation was studied by Side-stream Dark Field (SDF) imaging with automatic assessment.
Results: We enrolled 13 patients in the non-COVID group (mean age 70 years, 6 women), and 15 in the COVID-19 group (64 years old, 3 women). The plasma concentrations of syndecan-1 were significantly higher in the COVID-19 group during all three days. Differences regarding other biomarkers were not statistically significant. The assessment of the sublingual microcirculation showed improvement on Day 2 in the COVID-19 group. Plasma levels of C-reactive protein (CRP) were significantly higher on the first two days in the COVID-19 group. Plasma syndecan-1 and CRP were higher in patients suffering from severe COVID-19 pneumonia compared to bacterial pneumonia patients.
Conclusions: These findings support the role of EG injury in the microvascular dysfunction in COVID-19 patients who require ICU.

Keywords: glycocalyx; pneumonia; sepsis.
 
Back
Top Bottom